Funding for this research was provided by:
EU Horizon2020 (733373)
Text and Data Mining valid from 2019-11-04
Received: 23 April 2019
Accepted: 25 October 2019
First Online: 4 November 2019
Ethics approval and consent to participate
: The study and its procedures were approved by the Sudan Government/Federal Ministry of Health/National Health Research Ethics Committee and Al-Neelain University research ethics committee. Verbal consent was obtained from community leaders, children or participants’ guardians on their behalf. During the survey, all children with trachomatous inflammation-follicular (TF) and/or trachomatous inflammation-intense (TI) were treated with a single height-based dose of oral azithromycin in accordance with WHO and national protocols.
: Not applicable.
: The authors declare that they have no competing interests.